Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (471-480 of 560) with videos related to

Pageof 56
Sort By:
Cancer Biology & Therapy|March 12, 2009
Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissuesChangqing Ma, Kelly M Quesnelle, Anthony Sparano, et al.
NPJ Breast Cancer|November 9, 2019
If we build it they will come: targeting the immune response to breast cancerMargaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, et al.
Journal of Translational Medicine|February 24, 2023
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimabDomenico Mallardo, Ester Simeone, Lucia Festino, et al.
The Journal of Experimental Medicine|December 18, 2024
Autocrine TGF-β1 drives tissue-specific differentiation and function of resident NK cellsColin Sparano, Darío Solís-Sayago, Nathan Sébastien Zangger, et al.
Journal of the National Cancer Institute|May 4, 2013
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breastLawrence J Solin, Robert Gray, Frederick L Baehner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratorySunil S Badve, Frederick L Baehner, Robert P Gray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2023
Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 TrialNathaniel S O'Connell, Fengmin Zhao, Ju-Whei Lee, et al.
Nature Aging|April 28, 2023
Single-cell profiling of immune system alterations in lymphoid, barrier and solid tissues in aged miceSinduya Krishnarajah, Florian Ingelfinger, Ekaterina Friebel, et al.
Cancer|November 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 StudyLakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, et al.
JAMA Oncology|October 16, 2025
Radiotherapy With a 12-Gene Expression Assay for Ductal Carcinoma In Situ: A Randomized Clinical TrialSeema A Khan, Justin Romanoff, Constantine Gatsonis, et al.
Pageof 56

Showing results (471-480 of 560) with videos related to

Sort By:
Pageof 56
Cancer Biology & Therapy|March 12, 2009
Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissuesChangqing Ma, Kelly M Quesnelle, Anthony Sparano, et al.
NPJ Breast Cancer|November 9, 2019
If we build it they will come: targeting the immune response to breast cancerMargaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, et al.
Journal of Translational Medicine|February 24, 2023
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimabDomenico Mallardo, Ester Simeone, Lucia Festino, et al.
The Journal of Experimental Medicine|December 18, 2024
Autocrine TGF-β1 drives tissue-specific differentiation and function of resident NK cellsColin Sparano, Darío Solís-Sayago, Nathan Sébastien Zangger, et al.
Journal of the National Cancer Institute|May 4, 2013
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breastLawrence J Solin, Robert Gray, Frederick L Baehner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratorySunil S Badve, Frederick L Baehner, Robert P Gray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2023
Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 TrialNathaniel S O'Connell, Fengmin Zhao, Ju-Whei Lee, et al.
Nature Aging|April 28, 2023
Single-cell profiling of immune system alterations in lymphoid, barrier and solid tissues in aged miceSinduya Krishnarajah, Florian Ingelfinger, Ekaterina Friebel, et al.
Cancer|November 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 StudyLakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, et al.
JAMA Oncology|October 16, 2025
Radiotherapy With a 12-Gene Expression Assay for Ductal Carcinoma In Situ: A Randomized Clinical TrialSeema A Khan, Justin Romanoff, Constantine Gatsonis, et al.
Pageof 56